Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study

被引:284
作者
Zakeri, Rosita [1 ]
Chamberlain, Alanna M. [2 ]
Roger, Veronique L. [2 ,3 ]
Redfield, Margaret M. [1 ,3 ]
机构
[1] Mayo Clin, Cardiorenal Res Lab, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
atrial fibrillation; heart failure; diastolic; population; prognosis; VENTRICULAR SYSTOLIC DYSFUNCTION; MORBIDITY CHARM PROGRAM; OLMSTED COUNTY; RHYTHM CONTROL; MORTALITY; RISK; PREVALENCE; REDUCTION; TRIAL; EPIDEMIOLOGY;
D O I
10.1161/CIRCULATIONAHA.113.001475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In patients with heart failure and preserved ejection fraction (HFpEF), atrial fibrillation (AF) may predate, concur with, or develop after HFpEF diagnosis. We sought to define the temporal relationship between AF and HFpEF, to identify factors associated with AF, and to determine the prognostic impact of prevalent and incident AF in HFpEF. Method and Results From 1983 to 2010, 939 Olmsted County, Minnesota, residents (age, 77 +/- 12 years; 61% female) newly diagnosed with HFpEF (EF 0.50) were evaluated. Baseline rhythm classification included prior AF (>3 months before HFpEF diagnosis), concurrent AF (+/- 3 months), or sinus rhythm. Incident AF (>3 months after HFpEF diagnosis) and all-cause mortality were ascertained through February 2012. Prior AF (29%) and concurrent AF (23%) were associated with older age, higher brain-type natriuretic peptide, and larger left atrial volume index at HFpEF diagnosis compared with sinus rhythm. Of HFpEF patients in sinus rhythm at diagnosis, 32% developed AF over a median follow-up of 3.7 years (interquartile range, 1.5-6.7 years; 69 events per 1000 person-years). Age and diastolic dysfunction were positively and statin use was inversely associated with incident AF. With no AF used as the referent, prior or concurrent AF (combined hazard ratio, 1.3; 95% confidence interval, 1.0-1.6; P=0.03) and incident AF, modeled as a time-dependent covariate (hazard ratio, 2.1; 95% confidence interval, 1.4-3.0; P<0.001), were independently associated with death after adjustment for pertinent covariates. Conclusions AF occurs in two thirds of HFpEF patients at some point in the natural history and confers a poor prognosis. Further study is required to determine whether intervention for AF may improve outcomes or if statin use can prevent AF in HFpEF.
引用
收藏
页码:1085 / 1093
页数:9
相关论文
共 46 条
[1]   Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure [J].
Ahmed, A ;
Thornton, P ;
Perry, GJ ;
Allman, RM ;
DeLong, JF .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (04) :421-426
[2]   Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study [J].
Alonso, Alvaro ;
Agarwal, Sunil K. ;
Soliman, Elsayed Z. ;
Ambrose, Marietta ;
Chamberlain, Alanna M. ;
Prineas, Ronald J. ;
Folsom, Aaron R. .
AMERICAN HEART JOURNAL, 2009, 158 (01) :111-117
[3]   Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic [J].
Anter, Elad ;
Jessup, Mariell ;
Callans, David J. .
CIRCULATION, 2009, 119 (18) :2516-2525
[4]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[5]   Systolic and diastolic heart failure in the community [J].
Bursi, Francesca ;
Weston, Susan A. ;
Redfield, Margaret M. ;
Jacobsen, Steven J. ;
Pakhomov, Serguei ;
Nkomo, Vuyisile T. ;
Meverden, Ryan A. ;
Roger, Veronique L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (18) :2209-2216
[6]   Atrial Fibrillation and Mortality in Heart Failure A Community Study [J].
Chamberlain, Alanna M. ;
Redfield, Margaret M. ;
Alonso, Alvaro ;
Weston, Susan A. ;
Roger, Veronique L. .
CIRCULATION-HEART FAILURE, 2011, 4 (06) :740-746
[7]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[8]   Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program [J].
Ducharme, Anique ;
Swedberg, Karl ;
Pfeffer, Marc A. ;
Cohen-Solal, Alain ;
Granger, Christopher B. ;
Maggioni, Aldo P. ;
Michelson, Eric L. ;
McMurray, John J. V. ;
Olsson, Lars ;
Rouleau, Jean L. ;
Young, James B. ;
Olofsson, Bertil ;
Puu, Margareta ;
Yusuf, Salim .
AMERICAN HEART JOURNAL, 2006, 152 (01) :86-92
[9]   Antiarrhythmic effect of statin therapy and atrial fibrillation - A meta-analysis of randomized controlled trials [J].
Fauchier, Laurent ;
Pierre, Bertrand ;
De labriolle, Axel ;
Grimard, Caroline ;
Zannad, Noura ;
Babuty, Dominique .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (08) :828-835
[10]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870